1. |
Montuschi P, Kharitonov SA, Ciabattoni G, et al. Exhaled 8 -isoprostane as a new non-invasive biomarker of oxidative stress in Cystic fibrosis. Thorax, 2000, 55: 205-209.
|
2. |
Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol,2001, 280: L1067 -L1082.
|
3. |
中華醫學會呼吸病學分會哮喘學組. 支氣管哮喘防治指南( 支氣管哮喘的定義、診斷、治療和管理方案) . 中華結核和呼吸雜志, 2008, 31: 177-185.
|
4. |
Montuschi P, Barnes PJ, Roberts LJ 2nd, et al. Isoprostane: markers and mediators of oxidative stress. FASEB J, 2004, 18: 1791 -1800 .
|
5. |
Helmersson J, Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids,2004, 61: 203.
|
6. |
Kirschvink N, Martin N, Fievez L, et al. Airway inflammation in cadmium exposed rats is associated with pulmonary oxidative stress and emphysema. Free Radical Research, 2006, 40 : 241-250 .
|
7. |
Caramori G, Papi A. Oxidants and asthma. Thorax, 2004, 59: 170 -173 .
|
8. |
Nadeem A, Raj HG, Chhabra SK. Increased oxidative stress in acute exacerbations of asthma. J Asthma, 2005 , 42: 42-45.
|
9. |
于進洪, 李軍濤, 李國翔, 等. COPD 急性加重期患者血清8 -isoprostane 水平與肺功能和動脈氧分壓的關系. 山東醫藥,2008, 48: 64-65 .
|
10. |
Li Yongxia, Chongsuvivatwong V, Geater A, et al. Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments? Respiration, 2008, 76: 317-323 .
|
11. |
Li Yongxia, Chongsuvivatwong V, Geater A, et al. Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med, 2009, 10: 95 -103.
|
12. |
Zhao JJ, Shimizu Y, Dobashi K, et al. The Relationship Between Oxidative Stress and Acid Stress in Adult Patients With Mild Asthma. J Investing Clin Immunol, 2008 , 18: 41-45.
|
13. |
Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol, 2002, 109 : 615-620.
|
14. |
劉翱, 李少瑩, 楊偉康, 等. 支氣管哮喘患者呼出氣冷凝液中8 -異前列腺素的研究. 中國呼吸與危重監護雜志, 2009 , 8, 337 -340.
|